Inactive Instrument

Highlights Avacta Group Plc London S.E.

Equities

GB0033519546

End-of-day quote London S.E. Other stock markets
- ^GBX	-

06-26	Sovereign Metals signs deal with Palladium Group	AN
06-26	Avacta Group plc Announces Board Changes	CI

Highlights

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Sovereign Metals signs deal with Palladium Group	06-26	AN
Windward wins deal; Kodal progresses at Bougouni	05-23	AN
Avacta Group plc Announces Successful Completion of First Cohort and Dosing of Three Patients of the Second Cohort in Arm 2 of Avacta's Ava6000 Phase 1 Trial	05-23	CI
EARNINGS: Avacta sales jump; Poolbeg loss narrows; Digital 9 NAV down	04-30	AN
Avacta Group Plc Reports Earnings Results for the Full Year Ended December 31, 2023	04-30	CI
Avacta Group plc Reports Data from the Ongoing Phase 1 Clinical Trial of AVA6000 At the AACR Annual Meeting	04-09	CI
Avacta doses third patient in drug conjugate trial for tumour tissue	03-21	AN
Avacta shareholders give AGM go-ahead to issue new shares	03-18	AN
EARNINGS AND TRADING: Harland & Wolff wins major Falklands contract	03-05	AN
Avacta increases placing size to GBP26 million thanks to strong demand	02-29	AN
AIM WINNERS & LOSERS: Beacon Energy and Avacta fall on fundraise	02-29	AN
Avacta plans fundraise to fund clinical development	02-28	AN
Avacta Group plc Provides Detailed Pre-Clinical, Clinical and Pharmacokinetic Data from the Phase 1A Dose Escalation Study	12-13	CI
Avacta loss widens on cost rise but clinical tests positive	23-09-28	AN
Earnings Flash (AVCT.L) AVACTA GROUP Reports H1 Revenue GBP11.9M	23-09-28	MT
Earnings Flash (AVCT.L) AVACTA GROUP Posts H1 Loss GBX-4.28	23-09-28	MT
Avacta Group Plc Reports Earnings Results for the Half Year Ended June 30, 2023	23-09-28	CI
Capital inks contract; Lansdowne becomes cash shell	23-09-20	AN
Avacta Group plc Announces Successful Completion of ALS-6000-101 Sixth Dose Escalation	23-09-19	CI
Avacta Announces Successful Completion of Fifth Dose Escalation in Ava6000 Phase 1 Clinical Study	23-06-21	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Avacta Group Plc London S.E.

Equities

GB0033519546

Highlights

Filters